Thoracoscopy for diagnosis and management of refractory hepatic hydrothorax

The prevalence of pleural effusion caused by hepatocirrhosis ranges from 0.4% to 30%. Some patients with hepatic hydrothorax (HH) fail to respond to aggressive medical management such as albumin application, diuretics, and thoracentesis, and remain refractory massive pleural fluid. The repeated suct...

Full description

Saved in:
Bibliographic Details
Published inChinese medical journal Vol. 119; no. 5; pp. 430 - 434
Main Authors Lin, Dian-jie, Zhang, Min, Gao, Gui-xin, Li, Bin, Wang, Mao-fen, Zhu, Ling, Xue, Li-fu
Format Journal Article
LanguageEnglish
Published China Department of Respiratory Diseases, Shandong University Shandong Provincial Hospital, Jinan 250002, China 05.03.2006
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The prevalence of pleural effusion caused by hepatocirrhosis ranges from 0.4% to 30%. Some patients with hepatic hydrothorax (HH) fail to respond to aggressive medical management such as albumin application, diuretics, and thoracentesis, and remain refractory massive pleural fluid. The repeated suctions to relieve the symptoms such as respiratory distress are associated with significant hyponatremia and hypoalbuminemia caused by the large volumes of fluid loss. Review of the literature has revealed that, to date, no therapy is ideal. This report describes our experiments in treating HH of patients with cirrhosis and ascites by thoracoscopy and talc poudrage, to offer our efforts to approach the pathogenesis of HH and to explore the new therapeutic strategy.
Bibliography:thoracoscopy
R656
talc poudrage
11-2154/R
pleurodesis
hepatic hydrothorax
hepatic hydrothorax; thoracoscopy; pleurodesis; talc poudrage
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0366-6999
2542-5641
DOI:10.1097/00029330-200603010-00016